// App-Quantinova.ai

2061 : Targetable signaling pathway mutations and progression of IDH-mutant glioma.

Researchers

Presenter

  • Hiroaki Wakimoto

Principal Investigators

  • William T. Curry

  • Leif W. Ellisen

  • Darrell R. Borger

  • Sarah-Maria Fendt

  • Matthew Vander Heiden

  • Tracy Batchelor

  • A. John Iafrate

  • Daniel P. Cahill

  • Kensuke Tateishi

  • Juxiang Chen

  • Lindsay K. Klofas

  • Nina Lelic

  • James C. Kim

  • Dora Dias-Santagata

  • Andrew S. Chi

  • Franziska Loebel

  • Dan Zhao

Medical Centers

  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA

  • Massachusetts Institute of Technology, Cambridge, MAVesalius Research Center, VIB, and University of Leuven, Leuven, Belgium

Locations

  • United States

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gliomas

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved